Full Breakdown
Glyphosate at the Supreme Court: MAHA Movement Confronts Trump-Era EPA Policies
4/29/2026, 3:55:39 AM
Background & Context
Glyphosate, the active ingredient in Roundup, was labeled “probably carcinogenic” by IARC in 2015, yet EPA’s 2020 review called it “not likely” to cause cancer. A 2018 lawsuit by a San Francisco groundskeeper settled for $289 million ($20.4 million), spurring suits against Bayer, which bought Monsanto. In February 2026 President Donald Trump signed an executive order prioritizing glyphosate production for agriculture and defense.
Core Event
On April 28 2026 the Supreme Court heard arguments in *Monsanto v. Durnell*, a case that could decide whether individuals may sue Bayer for glyphosate-related cancer. Outside the Court, the Make America Healthy Again (MAHA) coalition staged the “People Versus Poison” rally, featuring Vani Hari, Kelly Ryerson, Del Bigtree, Alex Clark and Senator Cory Booker.
Official Statements & Responses
EPA said it is committed to transparency with MAHA; order declares glyphosate essential for U.S. farms and military, tasking Secretary Brook Rollins. Kennedy Jr. said the order puts America first for defense and food. Bayer CEO Bill Anderson said companies should not be penalized when they meet warning-label rules; Kush Desai said administration has plans to build on MAHA wins.
Criticism & Opposition
EPA’s deregulatory agenda betrays its health mission. David Murphy called support for Bayer “appalling.” Kelly Ryerson warned “interests poured” after industry allies filled EPA posts. Alexandra Muñoz called EPA actions “PR stunts” that falsely claim alignment. Sarah Vogel (EDF) said administration is “scrambling to give base a bone.” Zen Honeycutt (Moms Across America) called the order “an egregious offense.”
Verbatim Quotes
- “You cannot claim to care about health while protecting poison. You cannot tell Americans to eat real food while protecting the cancer-causing chemicals sprayed on it,” — Vani Hari, Food Babe, MAHA activist
- “What I see is an administration scrambling to try to give this grassroots base a bone, and I don't think they're buying it because they're actually following these issues,” — Sarah Vogel, Environmental Defense Fund
Conflicting Reports & Gaps
IARC’s 2015 “probably carcinogenic” classification conflicts with EPA’s 2020 finding that glyphosate is “not likely” carcinogenic. Protest attendance estimates differ: Vani Hari expected over 1,000 participants, while observers counted only a few hundred. EPA cites adding microplastics and pharmaceuticals to the Contaminant Candidate List as progress, yet critics note the list has historically led to little regulatory action.
Why It Matters
The Supreme Court ruling will determine whether Bayer can avoid state lawsuits over glyphosate, affecting legal recourse for alleged victims and prompting potential EPA regulatory changes. The decision also influences MAHA’s leverage in the 2026 midterms, as a pro-Bayer outcome would bolster the administration’s deregulatory agenda, while a plaintiff-friendly ruling could spur congressional action on pesticide liability.
What’s Next
The Court is slated to issue its decision in June 2026. The EPA plans to complete its glyphosate safety review later this year, and both parties are positioning pesticide policy as a key issue in the November 2026 midterm campaigns.
